Carregant...
Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies
Maintaining bone health remains a clinical challenge in patients with prostate cancer (PC) who are at risk of developing metastatic bone disease and increased bone loss due to hormone ablation therapy. In patients with cancer-treatment induced bone loss (CTIBL), antiresorptive agents have been shown...
Guardat en:
| Publicat a: | Int J Endocrinol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi Publishing Corporation
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4329828/ https://ncbi.nlm.nih.gov/pubmed/25802521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/838202 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|